{
  "docId": "019de072-a701-779d-b9c1-29622b36dd41",
  "docSlug": "f2c95dae10c304072442cd11deed84ec",
  "documentTitle": "Bausch Health Companies | Results Presentation Deck | 53 slides",
  "authorId": "bausch-health-companies",
  "authorName": "Bausch Health",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2022-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.3333334,
  "pageNumber": 10,
  "pageCount": 53,
  "prevPage": 9,
  "nextPage": 11,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "balanced",
  "nDataPoints": 48,
  "notes": "Includes footnotes regarding non-GAAP measures and segment reporting changes.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de072-a701-779d-b9c1-29622b36dd41/10",
  "deckHref": "/decks/019de072-a701-779d-b9c1-29622b36dd41",
  "deckJsonHref": "/decks/019de072-a701-779d-b9c1-29622b36dd41.json",
  "deckAnchorHref": "/decks/019de072-a701-779d-b9c1-29622b36dd41#slide-10",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.7,
        "x": 0.26,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "1. This is a non-GAAP measure. See Slide 2 and Non-GAAP Appendix for further information on non-GAAP measures and ratios. 2. Commencing in the first quarter of 2022, the Company operates in the following reportable segments.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "8eb200ce-e160-46b1-8d0d-597665da7175",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.65,
        "w": 0.92,
        "x": 0.04,
        "y": 0.175
      },
      "kind": "table",
      "text": "Revenue table showing segments (Salix, International, Diversified Products, Solta, Bausch + Lomb) with 3.31.22 vs 3.31.21 figures and growth percentages.",
      "attrs": null,
      "subkind": "data",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0f270cf3-13c7-4f11-b1d9-e9ceb618ebb1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.35,
        "x": 0.18,
        "y": 0.06
      },
      "kind": "title",
      "text": "1Q22 Revenue Results",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4762072b-2e4a-46f4-a241-9770527dd8e7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Table data",
      "slug": "table-data",
      "agent": null,
      "layer": "slide",
      "matchId": "fd547bde-7cb4-4a80-94f7-456f41003376",
      "evidence": "table/data: Revenue table showing segments (Salix, International, Diversified Products, Solta, Bausch + Lomb) with 3.31.22 vs 3.31.21 figures and growth percentages.",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [],
  "loops": [
    {
      "to": 19,
      "from": 9,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "7720718b-ea2d-4109-9564-eb09c0194463",
      "evidence": "Financial results and leverage discussion",
      "position": 0,
      "objective": "Highlighting the need for strategic alternatives",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}